Also, let’s keep in mind that the original draft of the USADA-Mayweather-Pacquiao drug-testing contract would have allowed USADA to grant a retroactive therapeutic use exemption to either fighter without notifying the Nevada State Athletic Commission or the opposing fighter’s camp. Indeed, even USADA’s “Detailed Correction” concedes, “USADA agreed to the request from Mr. Pacquiao’s representatives that USADA provide mutual notification to both fighters upon the approval of a TUE.”
In other words, if Pacquiao’s representatives hadn’t insisted upon notification, Mayweather’s retroactive therapeutic use exemption would most likely have remained a secret between Mayweather and USADA.
In other words, if Pacquiao’s representatives hadn’t insisted upon notification, Mayweather’s retroactive therapeutic use exemption would most likely have remained a secret between Mayweather and USADA.
Comment